skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 170567 Add to Shopping cart Find in a Library
Title: Drug Control: Planned Actions Should Clarify Counterdrug Technology Assessment Center's Impact
Corporate Author: US Government Accountability Office
General Government Division
United States of America
Date Published: 1998
Page Count: 46
Sponsoring Agency: Azimuth Inc.
Fairmont, WV 26554
NCJRS Photocopy Services
Rockville, MD 20849-6000
US Government Accountability Office
Washington, DC 20548
Publication Number: GAO/GGD-98-28
Sale Source: Azimuth Inc.
1000 Technology Drive, Suite 3120
Fairmont, WV 26554
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Type: Program/Project Description
Language: English
Country: United States of America
Annotation: This is a Report to the Chairman, Caucus on International Narcotics Control, US Senate, concerning the operations and contributions of the Counterdrug Technology Assessment Center.
Abstract: Congress established the Counterdrug Technology Assessment Center (CTAC) within the Office of National Drug Control Policy to oversee and coordinate counterdrug technology initiatives with related Federal activities, prevent unnecessary duplication of research and development efforts, and fund counterdrug research projects. The report discusses in detail CTAC's coordination process shortcomings, including: (1) the S&T Committee does not reflect the Committee's current composition, responsibilities, and relationship to CTAC; (2) the full S&T Committee met irregularly and often was not included in decision-making about which counterdrug technologies should be funded; (3) CTAC did not regularly reassess the counterdrug technology needs of Federal agencies to ensure that its listing was current; (4) CTAC did not systematically consider and fund counterdrug technology needs of state and local agencies; (5) CTAC approved many R&D projects for funding even though they lacked comprehensive transitional plans; and (6) CTAC had no system to determine the extent to which their efforts had identified and helped to avoid unnecessary duplication. Notes, tables, figure, appendixes, abbreviations
Main Term(s): Controlled Substances
Index Term(s): Drug information; Drug Policy; Drug regulation; Drug research; Federal programs; Office of National Drug Control Policy (ONDCP); Reports; Research and development; Science and Technology
Note: DCC
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.